Invasive pneumococcal disease in England and Wales: Vaccination implications

Karen Sleeman, Kyle Knox, Robert George, Elizbeth Miller, Pauline Waight, David Griffiths, Androulla Efstratiou, Karen Broughton, Richard T. Mayon-White, E. R. Moxon, D. W. Crook

Research output: Contribution to journalArticlepeer-review

110 Citations (Scopus)

Abstract

Knowledge of the epidemiology of invasive pneumococcal disease (IPD) will aid in planning the use of pneumococcal vaccines. A United Kingdom (UK)-based surveillance in England and Wales (1995-1997) of 11,528 individuals with IPD and a local enhanced surveillance in the Oxford (UK) area (1995-1999) have been analyzed. IPD has a high attack rate in children, with 37.1-48.1 cases per 100,000 infants <1 year old per year, and in older persons, with 21.2-36.2 cases per 100,000 persons >65 years old per year, for England, Wales, and Oxford. The 7-valent conjugate vaccine includes serotypes causing ≤79% of IPD in children <5 years old, but only 66% in adults >65 years old. The data also indicate that IPD varies by serotype, age, and country, emphasizing that the epidemiology of IPD is heterogeneous and requires continued surveillance.

Original languageEnglish
Pages (from-to)239-246
Number of pages8
JournalJournal of Infectious Diseases
Volume183
Issue number2
DOIs
Publication statusPublished - 15 Jan 2001

Bibliographical note

Funding Information:
Financial support: Public Health Laboratory Service; University Department of Paediatrics, Oxford, which is funded in part by Aventis Pasteur (to Oxford Vaccine Group).

Fingerprint

Dive into the research topics of 'Invasive pneumococcal disease in England and Wales: Vaccination implications'. Together they form a unique fingerprint.

Cite this